Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis

Therapeutic Advances in Musculoskeletal Disease · Published 2026-07-01 · DOI 10.1177/1759720x261466904

Free full text

Authors (9)

Balqis Istiqomah Gusbela, Min Huei Hsu, Chun Feng Huang, Meng Huang Wu, Daniel C. A. Nugroho, Muhammad Solihuddin Muhtar, Christine Y. Lu, Ming Hung Teng, Jason C. Hsu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gusbela, B., Hsu, M., Huang, C., et al. (2026). Cardiovascular safety of romosozumab versus denosumab for osteoporosis treatment: a multinational real-world data analysis. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720x261466904

Related articles

• A transfer learning–based approach for automated bone fracture classification in X-ray imaging · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• High-dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexate · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Temporal trends and future projections of hand osteoarthritis burden in China from 1990 to 2021 · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Towards an individualised approach to pain management in inflammatory arthritis · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Patient and public involvement in musculoskeletal pain research: using mutual learning to improve research quality · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Cardiometabolic disease and risk of total knee arthroplasty among patients with knee osteoarthritis receiving intra-articular hyaluronic acid: a real-world cohort study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Serum interleukin-8 levels relate to disease activity in patients with rheumatoid arthritis · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal